Patents Examined by Jane T. Fan
  • Patent number: 5352796
    Abstract: Unnatural amino acids are provided which can be incorporated into peptides which either inhibit or promote the secretion of gonadotropins by the pituitary gland and inhibit the release of steroids by the gonads. These unnatural amino acids are useful in the synthesis of peptides and have the formula (a): ##STR1## where W is (CH.sub.2).sub.n or ##STR2## n is an integer from 1 to 6; j=1,2 or 3, and preferably, Y is N--CN, X is NH and R.sub.2 is alkyl, modified alkyl, alkenyl, alkynyl, aryl or methyl pyridyl; or the formula (b): ##STR3## where R.sub.11 is H or acyl and W is as defined in (a), and preferably R.sub.11 is H and W is ##STR4## Disclosed are peptides that are analogs of the decapeptide GnRH wherein there is at least one residue of an unnatural amino acid in the 3-, 5-, 6- and/or 8-positions.
    Type: Grant
    Filed: June 17, 1993
    Date of Patent: October 4, 1994
    Assignee: The Salk Institute For Biological Studies
    Inventors: Carl A. Hoeger, Jean E. F. Rivier, John S. Porter
  • Patent number: 5342847
    Abstract: The invention relates to the new dimethyl 2,6-dimethyl-1-n-propyl-4-(trifluoro-methylphenyl)-1,4-dihydropyridine-3-d icarboxylate, a process for its preparation and its use as a medicament in ischaemic diseases which are associated with disorders of the microcirculation. This action can occur both in the peripheral and in the cerebral vascular system.
    Type: Grant
    Filed: January 16, 1993
    Date of Patent: August 30, 1994
    Assignee: Bayer Aktiengesellschaft
    Inventors: Otto Behner, Hartmund Wollweber, Siegfried Goldmann, Bruno Rosen, Siegfried Zaiss
  • Patent number: 5340825
    Abstract: Novel pro-drugs ##STR1## the variables are as defined in the specification. New and unnatural dipeptoids of .alpha.-substituted Trp-Phe derivatives useful as agents in the treatment of obesity, hypersecretion of gastric acid in the gut, gastrin-dependent tumors, or as antipsychotics are disclosed. Further, the dipeptoids are antianxiety agents and antiulcer agents. They are agents useful for preventing the response to the withdrawal from chronic treatment or with use of nicotine, diazepam, alcohol, cocaine, caffeine, or opioids. The pro-drugs are also useful in treating and/or preventing panic attacks. Also disclosed are pharmaceutical compositions and methods of treatment using the pro-drugs as well as processes for preparing them and novel intermediates useful in their preparation. An additional feature of the invention is the use of the subject pro-drug compounds in diagnostic compositions.
    Type: Grant
    Filed: July 12, 1991
    Date of Patent: August 23, 1994
    Assignee: Warner-Lambert Company
    Inventors: David C. Horwell, Martyn C. Pritchard, Reginald S. Richardson
  • Patent number: 5332750
    Abstract: New 1,2-dihydro-2-oxopyridines of formula I ##STR1## in which R is the radical ##STR2## and R.sup.1 to R.sup.6 and X are as defined herein,and their salts, have antagonistic properties towards angiotensin II and can be used for the treatment of hypertension, aldosteronism and cardiac insufficiency.
    Type: Grant
    Filed: April 22, 1993
    Date of Patent: July 26, 1994
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Werner Mederski, Norbert Beier, Pierre Schelling, Ingeborg Lues, Klaus-Otto Minck
  • Patent number: 5330994
    Abstract: A novel compound of the following formulas useful in treating immune-related diseases, inflammation, stoke, epilepsy, dystonias, psychoses, anxiety, and depression: ##STR1##
    Type: Grant
    Filed: March 24, 1992
    Date of Patent: July 19, 1994
    Assignee: Warner-Lambert Company
    Inventors: Yazhong Pei, Haile Tecle
  • Patent number: 5330997
    Abstract: Certain 1H-indazole-3-acetic acid derivatives, and their pharmaceutically-acceptable esters and salts, are inhibitors of the aldose reductase enzyme, and so are useful in the treatment of diabetic complications.
    Type: Grant
    Filed: February 24, 1993
    Date of Patent: July 19, 1994
    Assignee: Pfizer Inc.
    Inventors: Banavara L. Mylari, William J. Zembrowski
  • Patent number: 5328925
    Abstract: The present invention relates to therapeutically active piperidine compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful as stimulants of the cognitive function of the forebrain and hippocampus of mammals and especially in the treatment of Alzheimer's disease, severe painful conditions and glaucoma.
    Type: Grant
    Filed: August 15, 1991
    Date of Patent: July 12, 1994
    Assignee: Novo Nordisk A/S
    Inventors: Per Sauerberg, Preben H. Olesen
  • Patent number: 5328918
    Abstract: This invention relates to substituted pyridinylamino-1H-indoles, 1H-indazoles, 2H-indazoles, benzo[b]thiophenes and 1,2-benzisothiazoles of the formula ##STR1## wherein Q is S, N or NR.sub.2 ;Y is CH, N or NR.sub.2 ;R.sub.1 is hydrogen, loweralkyl, loweralkynyl, loweralkenyl, arylloweralkyl, loweralkoxycarbonylaminoloweralkylcarbonyl, arylloweralkoxycarbonylaminoloweralkylcarbonyl, aminoloweralkylcarbonyl, loweralkoxycarbonyl or acyl;R.sub.2 is hydrogen or loweralkyl;R.sub.3 is hydrogen or loweralkyl;X is hydrogen, loweralkyl, halogen; andn is 0 or 1; or a pharmaceutically acceptable acid addition salt thereof.The compounds of this invention are useful in the treatment of memory dysfunctions characterized by a cholinergic deficit such as the type associated with Alzheimer's disease and other memory disorders.
    Type: Grant
    Filed: March 25, 1993
    Date of Patent: July 12, 1994
    Assignee: Hoechst-Roussel Pharmaceuticals Inc.
    Inventors: Richard C. Effland, Joseph T. Klein, Lawrence L. Martin
  • Patent number: 5328920
    Abstract: There are disclosed various compounds of the formula below, ##STR1## where R, R.sub.1, W, X, Y and Z are as defined in the specification; which are useful for alleviating various memory dysfunctions such as Alzheimer's disease, as modulators of neurotransmitter functions such as serotonergic and adrenergic, and as such are useful as antidepressants, anxiolytics, atypical antipsychotics, antiemetics, and for the treatment of personality disorders such as obsessive compulsive disorder.
    Type: Grant
    Filed: October 21, 1992
    Date of Patent: July 12, 1994
    Assignee: Hoechst-Roussel Pharmaceuticals Incorporated
    Inventors: Richard C. Effland, Joseph T. Klein, Lawrence L. Martin, Gregory M. Shutske, Kevin J. Kapples, John D. Tomer, IV
  • Patent number: 5328924
    Abstract: The present invention relates to therapeutically active azacyclic compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful as stimulants of the cognitive function of the forebrain and hippocampus of mammals and especially in the treatment of Alzheimer's disease, severe painful conditions and glaucoma.
    Type: Grant
    Filed: August 14, 1991
    Date of Patent: July 12, 1994
    Assignee: Novo Nordisk A/S
    Inventors: Per Sauerberg, Preben H. Olesen
  • Patent number: 5328923
    Abstract: The present invention relates to therapeutically active azacyclic compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful as stimulants of the cognitive function of the forebrain and hippocampus of mammals and especially in the treatment of Alzheimer's disease, severe painful conditions and glaucoma.
    Type: Grant
    Filed: August 13, 1991
    Date of Patent: July 12, 1994
    Assignee: Novo Nordisk A/S
    Inventors: Per Sauerberg, Preben H. Olesen
  • Patent number: 5326772
    Abstract: Optically pure diaryl compounds of formula I ##STR1## wherein the substituents and symbols have the meanings given int eh specification are proposed as active ingredients in medicaments for the treatment of tumors.
    Type: Grant
    Filed: May 7, 1992
    Date of Patent: July 5, 1994
    Assignee: Byk Gulden Lomberg Chemische Fabrik GmbH
    Inventors: Kurt Klemm, Wolf-Rudiger Ulrich, Dieter Flockerzi
  • Patent number: 5321002
    Abstract: Herbicidal compounds, compositions containing them, and a method for controlling weeds by application of the compositions are disclosed. The herbicidal compounds are 2-(1-aryl-4-cyano-5-pyrazolylmethyleneiminooxy)alkanoic acid derivatives of the structure: ##STR1## in which R is lower alkyl, lower alkenyl, or lower alkynyl, each optionally substituted with halogen, or CH(R.sup.1)--C(O)--Y--R.sup.2 ; R.sup.1 is hydrogen or lower alkyl; R.sup.2 is one of a variety of substituents; Y is O or NH; Z is lower alkyl or lower alkoxy; and Ar is 3-chloro-5-trifluoromethyl-2-pyridyl, 2,6-dichloro-4-trifluoromethylphenyl, or 2,4,6-trichlorophenyl.
    Type: Grant
    Filed: August 11, 1993
    Date of Patent: June 14, 1994
    Assignee: FMC Corporation
    Inventor: Lester L. Maravetz
  • Patent number: 5314898
    Abstract: Compounds having the formula I: ##STR1## are inhibitors of the 5-lipoxygenase enzyme and inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, psoriasis, uveitis, and allograft rejection and in preventing the formation of atherosclerotic plaques.
    Type: Grant
    Filed: June 29, 1992
    Date of Patent: May 24, 1994
    Assignees: Merck & Co., Inc., Merck Frosst Canada Inc.
    Inventors: John Y. L. Chung, Robert A. Reamer, Yves Girard, Pierre Hamel
  • Patent number: 5314899
    Abstract: The present invention is directed to compounds, compositions and methods of treating pain, and derivatives that have potent analgetic activity. The compounds have the formula: ##STR1## wherein R.sup.1 is selected from H, lower alkyl, C.sub.3 -C.sub.9 cycloalkyl, acyl, and C.sub.3 -C.sub.9 cycloalkylalkyl, haloalkyl, alkenyl, alkynyl, hydroxyalkyl, or C.sub.3 -C.sub.8 cycloalkenyl or C.sub.3 -C.sub.8 cycloalkynyl; and wherein R is selected from cycloalkyl, aryl, heteroaryls (selected from the group consisting of pyridyl, thienyl, furanyl, imidazolyl, pyrazinyl, and pyrimidyl) or phenoxy and wherein said R groups can be substituted with hydroxyl, C.sub.1 -C.sub.6 lower alkyl, C.sub.2 -C.sub.6 alkenyl, C.sub.1 -C.sub.6 lower alkoxyl, halo, C.sub.1 -C.sub.6 haloalkyl, amino, C.sub.1 -C.sub.6 alkylamino and C.sub.2 -C.sub.10 dialkylamino, and sulfonamido or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: March 3, 1992
    Date of Patent: May 24, 1994
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: John W. Daly, Thomas F. Spande, Hugo M. Garraffo
  • Patent number: 5310920
    Abstract: The present invention relates to novel N-vinylimidazolidine derivatives of the following formula (1), a process for producing them, an insecticide containing the derivatives as an effective ingredient, and novelintermediates. The derivatives (1) are useful as agricultural chemicals (particularly, as insecticides) in the fields of agriculture, and the intermediates are useful in various industrial fields, especially as intermediates for agricultural chemicals. ##STR1## where R.sup.1, R.sup.2, Z are as defined in the specification.
    Type: Grant
    Filed: December 15, 1992
    Date of Patent: May 10, 1994
    Assignee: Mitsui Toatsu Chemicals, Inc.
    Inventors: Kenji Kodaka, Michihiko Nakaya, Katsutoshi Kinoshita, Koichi Ebihara, Hirozumi Matsuno, Shirou Shiraishi, Kazutomi Ohnuma, Ei-ich Yamada
  • Patent number: 5308855
    Abstract: Insecticidal guanidine derivatives of the formula ##STR1## wherein Z represents an optionally substituted five- or six-membered ring containing at least one ring hetero atom selected from the group consisting of oxygen, sulfur and nitrogen,R.sup.1 represents hydrogen atoms or a C.sub.1-4 alkyl group, R.sup.2 and R.sup.3 each independently represents hydrogen, C.sub.1-4 alkyl, C.sub.1-4 haloalkyl or optionally substituted phenyl,R.sup.4 and R.sup.5 each independently represents hydrogen, C.sub.1-4 alkyl, C.sub.3-4 alkenyl, C.sub.3-4 alkynyl, optionally substituted benzyl or a group of the formula Z-C(R.sup.1)H-,n represents the integer 2 or 3, andY represents nitro or cyano.
    Type: Grant
    Filed: December 7, 1992
    Date of Patent: May 3, 1994
    Assignee: Nihon Bayer Agrochem
    Inventors: Shin-ichi Tsuboi, Koichi Moriya, Yumi Hattori, Shinzaburo Sone, Katsuhiko Shibuya
  • Patent number: 5308854
    Abstract: Novel aminopyridones inhibit HIV reverse transcriptase, and are useful in the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, anti-infectives, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
    Type: Grant
    Filed: November 4, 1992
    Date of Patent: May 3, 1994
    Assignee: Merck & Co., Inc.
    Inventors: Jacob M. Hoffman, Jr., Walfred S. Saari, Clarence S. Rooney, John S. Wai
  • Patent number: 5302605
    Abstract: Novel 3-picoline-N-oxides of formula I ##STR1## wherein R.sub.1 and R.sub.2 independently of each other are hydrogen or halogen, R.sub.3 is hydrogen or C.sub.1 -C.sub.4 alkyl, n is the number two or three, and Y is nitrogen or the methine group, can be used as pesticides. Especially insects are controlled.
    Type: Grant
    Filed: September 11, 1991
    Date of Patent: April 12, 1994
    Assignee: Ciba-Geigy Corporation
    Inventors: Odd Kristiansen, Laurenz Gsell, Peter Maienfisch
  • Patent number: 5298520
    Abstract: A class of substituted imidazole, triazole and tetrazole derivatives are selective agonists of 5-HT.sub.1 -like receptors and are therefore useful in the treatment of clinical conditions, in particular migraine and associated disorders, for which a selective agonist of these receptors is indicated.
    Type: Grant
    Filed: January 28, 1993
    Date of Patent: March 29, 1994
    Assignee: Merck Sharp & Dohme Limited
    Inventors: Raymond Baker, Victor G. Matassa, Leslie J. Street